Research Studies

We are continuous working with new lines of treatment that have become the new hope for many patients.

Breast

Type of Cancer: Breast Sponsor: Sanofi Phase / Design: Phase 2 Randomized Open label Population: Locally advanced Not amenable to surgery / Radio the OR Metastatic Disease ER (+) &…

Breast

Type of Cancer: Breast Sponsor: Sanofi Phase / Design: Phase 2 Window Study Population: Localized & operable: Stage IIStage III Newly diagnosed, Pre-operative post-menopausal ER(+) & HER-2 (-)

Hepatocellular

Type of Cancer: Hepatocellular Sponsor: Merck Phase / Design: Phase 3 Randomized Double-blind Population: Incurable Nonmetastatic HCC No macrovascular invasion. Not amenable to transplant All lesions amenable to TACE in…

Myeloma

Type of Cancer: Relapsed and/or refractory multiple myeloma (RRMM) Sponsor: Sanofi Phase / Design: Observational Population:

NSCLC

Type of Cancer: NSCLC Sponsor: Merck Phase / Design: Phase 3 Randomized Open label (Rescue site) Population: Metastatic EGFR mutation (-)  

NSCLC

Type of Cancer: NSCLC Sponsor: BMS Phase / Design: Phase 3 Randomized Open label Population: Locally advanced: Stage IIIA, IIIB, or IIIC Unresectable Amenable to Chemoradiotherapy Naïve EGFR mutation (-)

NSCLC

Type of Cancer: NSCLC Sponsor: BMS Phase / Design: Phase 3 Randomized Double-blind Population: Resectable Stage II-IIIB Naïve EGFR mutation (-)
Menu